Private equity investment in U.S. healthcare facilities has surged over the past decade. These firms have been especially active in the fertility sector, where costly treatments such as in vitro fertilization, or IVF, are often not covered by traditional insurance. A University of Michigan research team is studying what this rapid growth in private equity involvement could mean for healthcare and patients over the long term. Learn more in this research spotlight from Michigan News.
